百洋医药：与君信就产品安博美签署经销协议

Core Viewpoint - Baiyang Pharmaceutical (301015) has signed a distribution agreement with Guangzhou Junxin Pharmaceutical Co., Ltd. on November 4, 2025, granting Baiyang exclusive rights to promote, sell, and distribute the product Anbomei® in a specific market during the agreement period [1]. Group 1 - Baiyang Pharmaceutical will have exclusive promotion and sales rights for Anbomei® [1]. - The agreement was signed on November 4, 2025 [1]. - The partner company in this agreement is Guangzhou Junxin Pharmaceutical Co., Ltd. [1].